ArrayIt Corporation is a majority shareholder of Avant Diagnostics, Inc., and thus will be a large shareholder of American Liberty Petroleum Corp.
SUNNYVALE, Calif., Dec. 31, 2014 (GLOBE NEWSWIRE) — Arrayit Corporation (OTCQB:ARYC) announces that its subsidiary Avant Diagnostics, Inc., a medical technology company developing cutting edge medical diagnostic tests, has been acquired by American Liberty Petroleum Corporation (OTCBB:OREO). The board of directors and a majority of shareholders of American Liberty Petroleum Corporation have authorized a number of corporate actions in order to complete the acquisition, including a reverse split, a name change, authorization of Preferred Stock, and filing the required SEC disclosure statements. Upon the effectiveness of these corporate actions, Gregg Linn, Avant’s CFO, will join the board of directors of the company as CEO and President.
In cooperation with Arrayit Corporation and DOCRO, Avant Diagnostics, Inc. is pursuing FDA approval of the market’s first large panel biomarker monitoring and screening test for ovarian cancer. OvaDx® is an advanced microarray-based test that measures the activation of the immune system in…
View original post 213 more words